Georgia's Online Cancer Information Center

Find A Clinical Trial

Assessing Financial Difficulty in Patients with Blood Cancers

Status
Temporarily Closed
Cancer Type
Leukemia
Trial Phase
Eligibility
18 Years and older, Male and Female
Study Type
Other
NCT ID
NCT03870633
Protocol IDs
A231602CD (primary)
A231602CD
NCI-2018-01708
A231602CD
Study Sponsor
Alliance for Clinical Trials in Oncology

Summary

This trial studies financial difficulty in patients with chronic lymphocytic leukemia and multiple myeloma. Assessment of financial difficulty may help to better understand the financial impact of cancer and come up with ways to help patients avoid financial problems during treatment.

Objectives

PRIMARY OBJECTIVES:
I. To estimate the proportion of patients with multiple myeloma (MM) and/or chronic lymphocytic leukemia (CLL) who report experiencing financial difficulty in the past 12 months.

SECONDARY OBJECTIVES:
I. To describe the association of patient report of financial difficulty with insurance status.
II. To describe the association of patient report of financial difficulty with receiving treatment at practices that report offering patients financial guidance through navigators or social workers, and controlling for patient socioeconomic status.
III. To describe the types of psychosocial, transportation and financial navigation interventions practices developing.
IV. To identify distinct patterns of financial burden among patients undergoing treatment for MM and/or CLL.
V. To examine the relationship between distinct patterns of financial burden with patient report of financial difficulty, patient socio-demographics, and patient disease characteristics.
VI. To estimate the proportion of patients with MM and/or CLL undergoing treatment who report receiving financial support in the past 12 months.
VII. To describe the association of patient report of receiving financial support with receiving treatment at practices offering patients financial guidance through navigators or social workers, and with socioeconomic status.
VIII. To describe the magnitude of patient concerns regarding treatment and costs of care.
IX. To describe the association of patient concerns regarding treatment and costs of care with patient socio-demographics, disease and practice characteristics.
X. To describe the association of financial difficulty with patient self-reported health and well-being.

OUTLINE:
Patients undergo medical chart abstraction within 1 week and complete telephone interview over 45-60 minutes within 8 weeks after registration.

Treatment Sites in Georgia

Augusta University Medical Center


1120 15th Street
Augusta, GA 30912
706-721-4430
www.augustahealth.org

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.